Studies on the protease inhibitor of Klebsiella aerogenes
Juhász, S.
Acta Veterinaria Hungarica 31(4): 121-123
1983
ISSN/ISBN: 0236-6290 PMID: 6234774 Document Number: 215879
Document emailed within 1 workday
Related Documents
Nichols, S.C.; Prichard, F.E.; James, A.M. 1979: Microcalorimetry studies of energy changes during the growth of Klebsiella aerogenes in simple salts/glucose media. 1 Establishment of standard conditions Microbios 25: 101-102Bowden, C.P.; James, A.M. 1985: Microcalorimetry studies of energy changes during the growth of Klebsiella aerogenes in simple salts/glucose media: growth in phosphate-limited medium Microbios 44(178): 75-85
Tchertkoff, V.; Brugarolas, A.M.; Sall, T. 1972: Pyogaseous liver abscess due to Klebsiella aerogenes New York State Journal of Medicine 72(22): 2801-2803
Tempest, D.W.; Neijssel, O.M.; Teixeira De Mattos, M.J. 1983: Regulation of metabolite overproduction in Klebsiella aerogenes Rivista di Biologia 76(2): 263-274
Sterkenburg, A.; Wouters, J.T. 1985: Phenotypic variations in cell envelope proteins of Klebsiella aerogenes Microbiological Sciences 2(5): 148-151
Gaillard, M.C.; Reichberg, S.B.; Nogueira, C.M.; Kilroe-Smith, T.A. 1993: Differences in elastase-binding activity of alpha 1-protease inhibitor and alpha 2-macroglobulin for asthma patients and control subjects with various alpha 1-protease inhibitor phenotypes Clinical Chemistry 39(4): 675-679
Crouch, J.R.; Atherton, J.G.; Platt, H. 1972: Venereal transmission of Klebsiella aerogenes in a thoroughbred stud from a persistently infected stallion Veterinary Record 90(2): 21-24
Traber, D.L.; Adams, T.; Sziebert, L.; Williams, P.; Traber, L.D. 1984: Failure of a protease inhibitor to affect the cardiopulmonary response to endotoxin when combined with a cyclooxygenase inhibitor Circulatory Shock 13(4): 319-323
Khomenko, I.M.; Kuiantseva, L.A.; Zarubinskiĭ, V.I.; Kaminskaia, V.P.; Koniukhova, N.A. 1986: Comparative clinico-laboratory studies of acute intestinal diseases of Klebsiella and Klebsiella and Proteus etiology in young children Pediatriia 3: 7-10
Della Porta, P.; Soeltl, R.; Krell, H.W.; Collins, K.; O'Donoghue, M.; Schmitt, M.; Krüger, A. 1999: Combined treatment with serine protease inhibitor aprotinin and matrix metalloproteinase inhibitor Batimastat (BB-94) does not prevent invasion of human esophageal and ovarian carcinoma cells in vivo Anticancer Research 19(5b): 3809-3816
Bondarenko, V.M.; Agapova, O.V.; Vinogradov, N.A. 2000: Role of bacterial protease degrading secretory immunoglobulin a in Klebsiella persistence Zhurnal Mikrobiologii Epidemiologii i Immunobiologii 2000(4 Suppl): 12-16
Piliero, P.J. 2004: Atazanavir: A novel once-daily protease inhibitor Drugs of Today 40(11): 901-912
Besson, C.; Jubault, V.; Viard, J.P.; Pialoux, G. 1998: Ketoacidosis associated with protease inhibitor therapy Aids 12(11): 1399-1400
Buch, H.J. 1970: Treatment of arthrosis with protease-inhibitor Contrykal Das Deutsche Gesundheitswesen 25(20): 947-950
Gastaldi, G.; Mattiello, A. 1971: Effect of a protease inhibitor on bacterial multiplication Pathologica 63(923): 223-231
Race, E. 2001: Cross-resistance within the protease inhibitor class Antiviral Therapy 6(Suppl 2): 29-36
Viciana, P.; Miralles-Martín, P.; Knobel, H.; Gatell, J.M. 1998: Prevention of opportunistic infections in the protease inhibitor era Enfermedades Infecciosas y Microbiologia Clinica 16 Suppl. 1: 1-10
Bierl, H. 2003: Atazanavir--first protease inhibitor for one dose administration Deutsche Medizinische Wochenschrift 128(39): 2039-2040
Cabot de Vega, E.; Fontecha Gómez, B.J.; Solé Arnau, R.; Pedrol Clotet, E. 1999: Peripheral lipodystrophy associated with protease inhibitor therapy Revista Clinica Espanola 199(8): 546-547
Eftekhari, N.; Ward, A.M.; Allen, R.; Greaves, M.W. 1980: Protease inhibitor profiles in urticaria and angio-oedema British Journal of Dermatology 103(1): 33-39